ANGELA NAPIERALA: Open Payments
NPI 1952017352 · BOWLING GREEN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,338 in 51 payments from 17 companies in 2025. Trend: 2023 $2,021 · 2024 $2,547 · 2025 $2,338
Food & beverage: $2,338
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $366 |
| Janssen Pharmaceuticals, Inc | 3 | $297 |
| Axsome Therapeutics, Inc. | 5 | $273 |
| Otsuka America Pharmaceutical, Inc. | 6 | $267 |
| Vanda Pharmaceuticals Inc. | 5 | $208 |
| ABBVIE INC. | 8 | $179 |
| ARGENX US, INC. | 1 | $125 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $120 |
| Neurocrine BioSciences, Inc. | 1 | $119 |
| Stryker Corporation | 1 | $116 |
Products named: AUSTEDO XR, INVEGA SUSTENNA, Auvelity, FANAPT, REXULTI, VRAYLAR, VYVGART, LUMRYZ.
Industry payments across OH — which companies pay providers there.
